Recombinant humanized monoclonal antibody to DR5 for use as a research grade Tigatuzumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to DR5 for use as a research grade Lexatumumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to DR5 for use as a research grade Conatumumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to DR5 for use as a research grade Drozitumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinantmonoclonal antibody to DR5 for use as a research grade TAS266 biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to DR5 for use as a research grade Benufutamab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to DR5 for use as a research grade Tigatuzumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to DR5 for use as a research grade Lexatumumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to DR5 for use as a research grade Conatumumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to DR5 for use as a research grade Drozitumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinantmonoclonal antibody to DR5 for use as a research grade TAS266 biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to DR5 for use as a research grade Benufutamab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.